Abstract:The gut immune system in the healthy intestine is anti-inflammatory, but can move to a pro-inflammatory state when the gut is challenged by pathogens or in disease. The nervous system influences the level of inflammation through enteric neurons and extrinsic neural connections, particularly vagal and sympathetic innervation of the gastrointestinal tract, each of which exerts anti-inflammatory effects. Within the enteric nervous system (ENS), three neuron types that influence gut immune cells have been identified, intrinsic primary afferent neurons (IPANs), vasoactive intestinal peptide (VIP) neurons that project to the mucosa, and cholinergic neurons that influence macrophages in the external muscle layers. The enteric neuropeptides, calcitonin gene-related peptide (CGRP), tachykinins, and neuromedin U (NMU), which are contained in IPANs, and VIP produced by the mucosa innervating neurons, all influence immune cells, notably innate lymphoid cells (ILCs). ILC2 are stimulated by VIP to release IL-22, which promotes microbial defense and tissue repair. Enteric neurons are innervated by the vagus, and, in the large intestine, by the pelvic nerves. Vagal nerve stimulation reduces gut inflammation, which may be both by stimulation of efferent (motor) pathways to the ENS, and stimulation of afferent pathways that connect to integrating centers in the CNS. Efferent pathways from the CNS have their anti-inflammatory effects through either or both vagal efferent neurons and sympathetic pathways. The final neurons in sympathetic pathways reduce gut inflammation by the action of noradrenaline on β2 adrenergic receptors expressed by immune cells. Activation of neural anti-inflammatory pathways is an attractive option to treat inflammatory bowel disease that is refractory to other treatments. Further investigation of the ways in which enteric reflexes, vagal pathways and sympathetic pathways integrate their effects to modulate the gut immune system and gut inflammation is needed to optimize neuromodulation therapy.

Enteric neuropathy and the vagus nerve: Therapeutic implications

Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases

Anti-inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction

The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis

Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders

Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis

Neuronal regulation of the gut immune system and neuromodulation for treating inflammatory bowel disease

Bioelectric neuromodulation for gastrointestinal disorders: effectiveness and mechanisms

Vagus Innervation in the Gastrointestinal Tumor: Current Understanding and Challenges.

Neuromodulatory Processes of the Brain–Gut Axis

Mechanisms of enteric neuropathy in diverse contexts of gastrointestinal dysfunction

Non-invasive vagus nerve stimulation: the future of inflammatory bowel disease treatment?

The enteric nervous system in gastrointestinal disease etiology

Communication between the gut microbiota and peripheral nervous system in health and chronic disease

Electroceuticals and Magnetoceuticals in Gastroenterology

Interactions between the microbiota and enteric nervous system during gut-brain disorders

Neuro-Immune Circuits Regulate Immune Responses in Tissues and Organ Homeostasis

Neuroimmunomodulation of vagus nerve stimulation and the therapeutic implications

Vagal sensory pathway for the gut-brain communication

The bowel and beyond: the enteric nervous system in neurological disorders

Nerves in gastrointestinal cancer: from mechanism to modulations